Acute and prophylactic management of migraine.
Although considerable advances have been made in the understanding and treatment of migraine, uncertainty about the management of this disorder remains. Once a diagnosis is established, an effective treatment plan should be developed that includes education for the patient about migraine and reassurance that the headaches are not caused by structural pathology, stress, or psychopathology. Rapidly effective acute treatment, nonpharmacologic treatment such as behavioral and lifestyle changes, preventive measures, and patient follow-up are other essential elements of migraine management.
Dodick
D W
DW
Mayo Clinic Scottsdale Headache Program, Department of Neurology, Mayo Clinic, Scottsdale, Arizona, USA.
D000208:Acute Disease; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000700:Analgesics / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D000927:Anticonvulsants / Q000627:therapeutic use; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D001521:Behavior Therapy / Q000379:methods; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002985:Clinical Protocols; D004359:Drug Therapy, Combination; D006801:Humans; D008881:Migraine Disorders / Q000628:therapy*; D012702:Serotonin Antagonists / Q000627:therapeutic use; D017366:Serotonin Receptor Agonists / Q000627:therapeutic use; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000700:Analgesics; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000927:Anticonvulsants; D000929:Antidepressive Agents, Tricyclic; D002121:Calcium Channel Blockers; D012702:Serotonin Antagonists; D017366:Serotonin Receptor Agonists; D017367:Selective Serotonin Reuptake Inhibitors